Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1
about
Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analysesRegulation of ALK-1 signaling by the nuclear receptor LXRbetaCasein kinase 2beta as a novel enhancer of activin-like receptor-1 signalingExpression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cellsHereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of diseaseBone morphogenetic protein-9 is a circulating vascular quiescence factorTransforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-betaInduction of transforming growth factor beta receptors following focal ischemia in the rat brainAbnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient miceEnhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signalingIdentification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signalingALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2Interaction between alk1 and blood flow in the development of arteriovenous malformationsGene profiling techniques and their application in angiogenesis and vascular development.ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expressionThe role of Smad signaling in hematopoiesis.The rat blood-brain barrier transcriptome.Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migrationSupermodels and disease: insights from the HHT mice.Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargementTransforming growth factor-betas in pre-gastrulation development of mammals (minireview).Investigation of endoglin wild-type and missense mutant protein heterodimerisation using fluorescence microscopy based IF, BiFC and FRET analyses.Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.Modulation of TGF-β signaling by endoglin in murine hemangioblast development and primitive hematopoiesis.Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growthHereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathwayGenetic aspects of cerebrovascular malformations.Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescenceTransforming growth factor-beta1 causes pulmonary microvascular endothelial cell apoptosis via ALK5.Expression levels of endoglin distinctively identify hematopoietic and endothelial progeny at different stages of yolk sac hematopoiesis.Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.Revealing protein networks and gene-drug connectivity in cancer from direct information.CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae.Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.Identification of NPM-ALK interacting proteins by tandem mass spectrometry.
P2860
Q24310450-BC738D94-B638-4013-9021-3BBC152C3208Q24312839-15A5AB3C-D03C-480E-BFB3-B7F141DB4C81Q24313348-9BEA2A4D-34D9-4622-898B-188EC971B8D9Q24337548-6B42BAEB-90ED-492F-9D03-D03FE844F4B2Q24645017-4A7A56E4-104A-4B92-BB1C-A8C989F2C497Q24657942-4A228E75-82CC-47B6-90E1-9AB4ACE2883AQ24793319-68495EA3-9FFA-4E3D-A744-BDEE9AC7E30FQ27312629-11FD7231-21B1-4539-B08F-F965CA348CFCQ28361871-DEA84379-9367-4354-9EB4-CF57F932DF8FQ28487916-95E25486-C3A4-4F92-BF08-6A4925AAB324Q28569079-F1ACF8C0-F162-4B28-BD1C-6546CE8BB244Q28575076-2D961878-983C-469A-B402-493D8260BD20Q28588420-DA32D701-2FA1-48AE-B0C3-58AF442BA1C8Q30498969-707D753B-EF0F-424B-A33E-36F01CCA8528Q30724640-8E97CEDF-F53C-4227-9A1F-3173ECBD6FD7Q30811602-F07B5F25-B704-40E4-BD9A-EB0A1EDF7CA5Q33222328-EC52435F-0F2F-439B-BB46-1E171F61313EQ33227764-F59A2032-12CC-4987-A3A6-A531FF1751B8Q33619784-7636AC54-EAE5-4EA2-ADE7-41A9B69163B8Q33705264-856F13F4-5B59-4033-BC46-3BB1D285FE8AQ33773949-052D7AD6-3605-4384-A43D-C930DEA07C71Q33854081-C8DC4801-B2A0-4C54-A423-2CBA5DB354F6Q33920526-C0432ED1-7C75-403C-9853-B352C873F305Q33981941-877ACCE7-65BB-4F49-86EF-EBACBAFF48D3Q34395261-4A2A8155-B9AA-417A-8E17-8273FBE755E9Q35114532-FB031E84-7B2E-476D-A09F-EF881624A94FQ35314203-B695773F-A68D-4B3B-9FB9-CD74066AF432Q35443250-FFE1FD50-E052-4178-9C59-A56933BFC214Q35533971-B178E39D-06EC-4DAE-9C42-669CAFCF862CQ36440899-E9EEE5AF-10DD-4959-A83A-4CD4AF8FF24AQ36921160-8E7236D5-570C-4929-8103-939B197EA637Q37080802-DA541FFA-D89A-4DB3-9B9E-0082C4C5FCBEQ37190206-59A02672-1C90-4C93-B973-A0565BB60C3AQ37227815-70CA1B06-0E3A-40AE-B28A-03931C11247EQ37897171-2C454715-CE2A-4438-A916-73AF3B5564AFQ38721721-CDF79723-9A86-4B98-9511-D6A805A0696FQ39357838-8EB4FB2A-6DE9-41AC-9784-7C754CC6B455Q40038167-AC0C130B-61FD-4F9A-83F4-CC5B3CF54C35Q40251249-602EC850-6945-444D-A372-F6075D6514EEQ40589160-A88459C9-7BDD-48D2-8D26-E56DCB1AF795
P2860
Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1
description
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1999
@ast
im April 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 9 April 1999)
@en
vedecký článok (publikovaný 1999/04/09)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/04/09)
@nl
наукова стаття, опублікована у квітні 1999
@uk
name
Assignment of transforming gro ...... d to the type I receptor ALK-1
@ast
Assignment of transforming gro ...... d to the type I receptor ALK-1
@en
Assignment of transforming gro ...... d to the type I receptor ALK-1
@nl
type
label
Assignment of transforming gro ...... d to the type I receptor ALK-1
@ast
Assignment of transforming gro ...... d to the type I receptor ALK-1
@en
Assignment of transforming gro ...... d to the type I receptor ALK-1
@nl
prefLabel
Assignment of transforming gro ...... d to the type I receptor ALK-1
@ast
Assignment of transforming gro ...... d to the type I receptor ALK-1
@en
Assignment of transforming gro ...... d to the type I receptor ALK-1
@nl
P2093
P356
P1476
Assignment of transforming gro ...... d to the type I receptor ALK-1
@en
P2093
P304
P356
10.1074/JBC.274.15.9984
P407
P577
1999-04-09T00:00:00Z